19 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18767925 | METHOD FOR PRODUCING AN ANTI-LAG-3 ANTIBODY | JUEDES, AMY E | 1644 | Final Rejection | Jul 09, 2024 |
| 18284788 | STABLE MULTISPECIFIC MOLECULE AND USE THEREOF | GAMETT, DANIEL C | 1647 | Non-Final OA | Sep 28, 2023 |
| 18367446 | METHOD OF TREATING CANCER COMPRISING ADMINISTRATION OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE | VAN DRUFF, SYDNEY | 1643 | Non-Final OA | Sep 12, 2023 |
| 18549797 | NOVEL DEALKOXYPHENYLATION REACTION | MILLER, DALE R | 1693 | Non-Final OA | Sep 08, 2023 |
| 18263124 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | GALSTER, SAMUEL LEONARD | 1693 | Non-Final OA | Jul 26, 2023 |
| 18272050 | ANTI-DLL3 ANTIBODY-DRUG CONJUGATE | PUTTLITZ, KARL J | 1646 | Non-Final OA | Jul 12, 2023 |
| 18265756 | STABLE TARGET-EDITING GUIDE RNA TO WHICH CHEMICALLY MODIFIED NUCLEIC ACID IS INTRODUCED | TATGE, LEXUS MARC | 1637 | Non-Final OA | Jun 07, 2023 |
| 18252838 | COMPLEX OF BETA-GLUCAN AND NUCLEIC ACID HAVING CONTROLLED PARTICLE SIZE | GALSTER, SAMUEL LEONARD | 1693 | Final Rejection | May 12, 2023 |
| 18036290 | TREATMENT OF MESOTHELIOMA BY ADMINISTRATION OF ANTI-B7-H3 ANTIBODY-DRUG CONJUGATE | CANELLA, KAREN A | 1643 | Non-Final OA | May 10, 2023 |
| 18252358 | NOVEL AMINOALKYL GLUCOSAMINIDE 4-PHOSPHATE DERIVATIVE | OLSON, ANDREA STEFFEL | 1693 | Non-Final OA | May 09, 2023 |
| 18025896 | A Scoring Method for an Anti-HER2 Antibody-Drug Conjugate Therapy | LU, CHENG | 1642 | Non-Final OA | Mar 11, 2023 |
| 18016864 | COMBINATION OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE WITH HER DIMERIZATION INHIBITOR | SKOKO III, JOHN JOSEPH | 1643 | Non-Final OA | Jan 18, 2023 |
| 18012900 | COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ATM INHIBITOR | STONEBRAKER, ALYSSA RAE | 1642 | Final Rejection | Dec 23, 2022 |
| 17787760 | FILM-COATED TABLETS HAVING SMOOTH SURFACE | KNIGHT, SAMANTHA JO | 1614 | Final Rejection | Jun 21, 2022 |
| 17641741 | CONJUGATE OF GalNAc-OLIGONUCLEOTIDE FOR DELIVERY TO LIVER AND MANUFACTURING METHOD THEREOF | VANHORN, ABIGAIL LOUISE | 1636 | Final Rejection | Mar 09, 2022 |
| 17616430 | STABLE TARGET-EDITING GUIDE RNA HAVING CHEMICALLY MODIFIED NUCLEIC ACID INTRODUCED THEREINTO | SULLIVAN, STEPHANIE LAUREN | 1635 | Final Rejection | Dec 03, 2021 |
| 17262590 | EFFECTIVE METHOD FOR MANUFACTURING ANTIBODY-DRUG CONJUGATE | VAN DRUFF, SYDNEY | 1643 | Non-Final OA | Jan 22, 2021 |
| 17058838 | TREATMENT OF HER2-MUTATED CANCER BY ADMINISTERING ANTI-HER2 ANTIBODY-DRUG CONJUGATE | VAN DRUFF, SYDNEY | 1643 | Final Rejection | Nov 25, 2020 |
| 16640914 | ANTIBODY-DRUG CONJUGATE PREPARATION AND LYOPHILIZATION FOR SAME | KIM, YUNSOO | 1641 | Non-Final OA | Feb 21, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial